Report on planning comparison of VMAT, IMRT and helical tomotherapy for the ESCALOX-trial pre-study.

Steffi Ulrike PigorschSeverin KampferMarkus OechsnerMichael C MayingerPetra MozesMichal DeveckaKerstin K KesselStephanie E CombsJan J Wilkens

Published in: Radiation oncology (London, England) (2020)

Different TPS for dose escalation reliably achieved high plan quality. Despite the very good results of HT planning for coverage, conformity, and homogeneity, the TPS also achieved acceptable results for IMRT and VMAT. Trial registration ClinicalTrials.gov Identifier: NCT01212354, EudraCT-No.: 2010-021139-15. ARO: ARO 14-01.

Keyphrases

phase iii
study protocol
phase ii
clinical trial
open label
functional connectivity